Katrien Grünberg has been appointed as Professor of Pathology at Radboud University/Radboud university medical center effective as of March 1st 2018.
Dr Grünberg received her training as a pathologist at VUmc in Amsterdam, where she then joined the staff as a consultant pathologist until 2015. The focus of her scientific and clinical work was on pulmonary pathology, including pulmonary vascular pathology in pulmonary hypertension. She was the board secretary and chair of the Dutch Scientific Society for Pathology (NVVP) until 2018.
In September 2015 Dr Grünberg was appointed head of the Pathology Department at Radboud university medical center. She is a member of the executive committee of the Center for Oncology. As Professor of Pathology she will focus on the development of highly specialized pathology in academic networks, molecular diagnostics and the application of artificial intelligence in digital pathology.
Related news items

Your heart rate as a thermometer Research Olympic athletes will be followed up during 4Daagse
18 July 2022Body temperature can be determined from heart rate. This is what research by the Radboudumc among Olympic athletes shows. Athletes can use this method during training to eventually perform better in the heat. The technique is now being further investigated among participants in the 4Daagse.
read more.aspx?width=3749&height=3370&ext=.jpg&type=BlockColumn1Zoom1)
Do insects help 4Days walkers to recover? a Radboudumc study
7 July 2022During the first 4Daagse since 2019, Radboudumc is investigating whether walkers will benefit from grounded protein-rich insects. It is known that animal proteins contribute to recovery after exercise, but the researchers want to find out whether proteins from insects can do this just as well.
read more
More than five million euros for research to improve palliative care Jeroen Hasselaar will lead research project with Horizon grant
15 June 2022 Jeroen Hasselaar will lead a large international research project. With a 5.3 million euro grant from the EU's Horizon program, he and his team want to improve palliative care for cancer patients, together with partners from nine European countries. read more.aspx?width=800&height=533&ext=.jpg&type=BlockColumn1Zoom1)
New test for Lyme disease is not reliable
15 June 2022 To determine whether someone has Lyme disease, doctors in the Netherlands often use antibody tests. For some time now, so-called cellular tests have been available on the market. However, the VICTORY study published in The Lancet Infectious Diseases has found that these tests are not reliable. read more.aspx?width=800&height=534&ext=.jpg&type=BlockColumn1Zoom1)
Aiosyn and Radboudumc are the first in the Netherlands to implement AI in the clinical pathology workflow Digital pathology slides will be screened with a quality control algorithm
4 April 2022 Aiosyn, a company that develops AI-powered computational pathology analysis for clinical diagnostics, and the department of pathology of Radboudumc, will collaborate to implement an algorithm for quality control of digitized histopathology tissue slides. read more